Demographic characterization of 34 healthy, HIV-uninfected newborns of either HIV-infected or HIV-uninfected mothers (demographic data from the mothers are shown as well)
| . | Newborn SR (n = 20) . | Newborn UC (n = 14) . |
|---|---|---|
| Age (d) | 30.8 ± 22.5 | 30.5 ± 24.1 |
| Gestational age (wk) | 37.2 ± 1.1 | 38.1 ± 1.9 |
| Gestational age < 37 wk | 6/20 (30%) | 3/14 (21%) |
| Birth weight (g) | 2680 ± 536 | 3071 ± 435 |
| Birth weight < 2500 g | 6/20 (30%) | 3/14 (21%) |
| Cesarean section | 16/20 | 1/14 |
| ZDV prophylaxis | 20/20 | 0/14 |
| HCV infection | 2/20 | 0/14 |
| CMV infection | 1/20 | 0/14 |
| HIV-infected mothers | HIV-uninfected mothers | |
| Maternal age (y) | 29.0 ± 9.2 | 30.4 ± 8.3 |
| Primiparity | 11/20 (55%) | 7/14 (50%) |
| Previous drug use* | 8/20 (40%) | 0/14 |
| STD† | 2/20 (10%) | 1/14 (7%) |
| . | Newborn SR (n = 20) . | Newborn UC (n = 14) . |
|---|---|---|
| Age (d) | 30.8 ± 22.5 | 30.5 ± 24.1 |
| Gestational age (wk) | 37.2 ± 1.1 | 38.1 ± 1.9 |
| Gestational age < 37 wk | 6/20 (30%) | 3/14 (21%) |
| Birth weight (g) | 2680 ± 536 | 3071 ± 435 |
| Birth weight < 2500 g | 6/20 (30%) | 3/14 (21%) |
| Cesarean section | 16/20 | 1/14 |
| ZDV prophylaxis | 20/20 | 0/14 |
| HCV infection | 2/20 | 0/14 |
| CMV infection | 1/20 | 0/14 |
| HIV-infected mothers | HIV-uninfected mothers | |
| Maternal age (y) | 29.0 ± 9.2 | 30.4 ± 8.3 |
| Primiparity | 11/20 (55%) | 7/14 (50%) |
| Previous drug use* | 8/20 (40%) | 0/14 |
| STD† | 2/20 (10%) | 1/14 (7%) |
SR = healthy HIV-uninfected children of HIV-infected mothers (seroreverters); UC = healthy children of HIV-negative women (uninfected controls); ZDV = zidovudine; HCV = hepatitis C virus; CMV = cytomegalovirus; STD = sexually transmitted disease. Mean ± standard deviation.
In all cases, drug use stopped at least 2 years before pregnancy.
Two chlamydial infections; 2 Candida albicans infections.